US Congressman Gregory Meeks Welcomes India's Decision to Resume Export of Surplus COVID-19 Vaccine
An influential US Congressman has welcomed India's decision to resume the export of surplus COVID-19 vaccines to meet its commitment to the COVAX global pool.
Washington, September 21: An influential US Congressman has welcomed India's decision to resume the export of surplus COVID-19 vaccines to meet its commitment to the COVAX global pool.
India's Health Minister Mansukh Mandaviya on Monday said the country will resume export of surplus COVID-19 vaccines in the fourth quarter of this year under the 'Vaccine Maitri' programme to meet its commitment to the COVAX global pool. Also Read | Amazon Bans 600 Chinese Brands From Its Store For Abusing Review Policy.
US Congressman Gregory Meeks' Tweet
He, however, asserted that vaccinating own citizens remains the topmost priority of the government. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and WHO. Also Read | Biden Administration Launches Response to Health Harms from Extreme Heat.
"I welcome today's announcement by the Government of India to resume COVID-19 vaccine exports," Congressman Gregory Meeks, the chairman of the powerful House Foreign Affairs Committee, said in a tweet on Monday.
"As the world's leading vaccine manufacturer, India's role is critical to defeating this pandemic," Meeks tweeted tagging an article by The New York Times. India had stopped the export of COVID-19 vaccines after the second wave of the COVID-19 pandemic hit the country in April this year.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)